Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
about
The unsolved mystery of apoA-I recycling in adipocyteThe major antigenic membrane protein of "Candidatus Phytoplasma asteris" selectively interacts with ATP synthase and actin of leafhopper vectors.Mitochondrial inhibitory factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterolPharmacological modulation of histone demethylase activity by a small molecule isolated from subcritical water extracts of Sasa senanensis leaves prolongs the lifespan of Drosophila melanogaster.Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells.ATP synthase: a molecular therapeutic drug target for antimicrobial and antitumor peptidesATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study.HDL endocytosis and resecretionLipid raft proteome reveals that oxidative phosphorylation system is associated with the plasma membrane.Development and characterization of mitochondrial membrane affinity chromatography columns derived from skeletal muscle and platelets for the study of mitochondrial transmembrane proteins.The Therapeutic Potential of Piceatannol, a Natural Stilbene, in Metabolic Diseases: A Review.A therapeutic connection between dietary phytochemicals and ATP synthase.ATP synthase: from single molecule to human bioenergetics.Biomolecular proteomics discloses ATP synthase as the main target of the natural glycoside deglucoruscin.The involvement of purinergic signalling in obesity.ATP synthase: the right size base model for nanomotors in nanomedicine.
P2860
Q28069220-10A19E03-E906-415A-AEB8-D3001A3F5984Q31028423-EEDA015E-4DC5-4248-B63F-0382DD758348Q34025964-38146D6B-0368-4643-8338-2A8D269736FBQ34342921-69D6B998-0C83-4A83-B496-0BC80136DD2DQ34662342-0AFE9866-DE5E-47AF-BE13-9C4C46EC9105Q36525469-A0F0642A-24B7-4285-9959-637D70127D4CQ36995302-40634D51-6304-4F28-8974-86DD812FD4D0Q37076538-CD3753F1-7703-42DD-9713-A76BA87FC2D9Q37226719-8CE59ACB-B6E7-4748-9A81-BE0725AEC85DQ37818312-25E451F2-5F52-4FCE-89DC-0F460A2F5FACQ38801948-776179E7-6B27-4A20-8C61-B64C57774F92Q39226373-17960030-0A28-4D75-ADFA-E22BB404FEA9Q40083367-545068B0-24BB-49E7-B6FE-CCCCCCD9A803Q41986963-CA1345C3-A368-49D4-9CCD-5F3A40AECEF4Q51604215-7AB18431-91D4-48C2-869D-C28E751FF23FQ52605605-49BD2489-7F48-4E89-874B-DB176D030408Q54372352-BBF98846-3DD8-4630-8B0E-002B4CBF4BFE
P2860
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
description
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Juli 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/07/24)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/07/24)
@nl
наукова стаття, опублікована в липні 2007
@uk
مقالة علمية (نشرت في 24-7-2007)
@ar
name
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@ast
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@en
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@nl
type
label
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@ast
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@en
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@nl
prefLabel
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@ast
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@en
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@nl
P2093
P2860
P921
P1433
P1476
Cell-surface H+-ATP synthase as a potential molecular target for anti-obesity drugs
@en
P2093
Hirofumi Shibata
Naokatu Arakaki
Tomihiko Higuti
Toshiyuki Kita
P2860
P304
P356
10.1016/J.FEBSLET.2007.06.041
P407
P577
2007-07-24T00:00:00Z